TCID | Name | Domain | Kingdom/Phylum | Protein(s) |
---|---|---|---|---|
2.A.106.1.1 | The Y615 protein | Bacteria |
Cyanobacteriota | Y615 of Synechocystis PCC6803 |
2.A.106.1.2 | Uncharacterized protein of 194 aas and 6 TMSs with two 3-TMS repeats. | Bacteria |
Actinomycetota | UP of Streptomyces griseus |
2.A.106.1.3 | Uncharacterized protein of 213 aas and 6 TMSs | Bacteria |
Chlorobiota | UP of Chlorobium chlorochromatii |
2.A.106.1.4 | Uncharacterized protein of 192 aas probably with 6 TMSs in a 3 + 3 TMS repeat unit. | Bacteria |
Pseudomonadota | UP of Acidovorax ebreus |
2.A.106.1.5 | Chloroplast thylakoid GDT-1-like protein or photosynthesis-affected protein-71, PAM71 or CCHA1 of 370 aas with 6 TMSs in a 3 + 3 TMS arrangement. It takes up Mn2+ and influences both Mn2+ and Ca2+ homeostasis in the chloroplast. It is necessary for photosystem II function due to its Mn2+ uptake activity (Schneider et al. 2016; Hoecker et al. 2017). It is an Mn2+/H+ exchanger, which transport Mn2+ from the chloroplast stroma into the acidic thylakoid lumen (Schneider et al. 2016). It might be a chloroplast-localized Ca2+/H+ antiporter as well (Wang et al. 2016) since it regulates Ca2+, Mn2+ and pH homeostasis and is required for chloroplast development. | Eukaryota |
Viridiplantae, Streptophyta | PAM71 orCCHA1 of Arabidopsis thaliana |
2.A.106.1.6 | Manganese (Mn2+):proton exchanger, CGLD1, of 340 aas (Schneider et al. 2016; ). | Eukaryota |
Viridiplantae, Chlorophyta | CGLD1 of Chlamydomonas reinhardtii (Chlamydomonas smithii) |
2.A.106.1.7 | Photosynthesis-affected mutant 71, PAM71 homologue, PAM71-HL, of 359 aas and 7 TMSs (Hoecker et al. 2017). Probably a manganese ion transporter; a member of the UPF0016 family. | Eukaryota |
Viridiplantae, Streptophyta | PAM71-HL of Arabidopsis thaliana (Mouse-ear cress) |
2.A.106.1.8 | Putative DL-lactate uptake porter of 184 aas and 6 - 7 TMSs (Deutschbauer et al. 2011). | Bacteria |
Pseudomonadota | SO_1071 of Shewanella oneidensis |
2.A.106.1.9 | Uncharacterized protein of 235 aas and probably 6 TMSs in a 3 + 3 TMS arrangement. | Archaea |
Euryarchaeota | UP of Haloarcula japonica |
2.A.106.1.10 | Actinomycetota protein of 200 aas and 6 TMSs in a 3 + 3 TMS arrangement. It is in the TMEM165/GDT1 family of proteins. | None |
Bacillati, Actinomycetota | AP of Marmoricola sp. |
2.A.106.1.11 | TMEM165/GDT1 family protein of 261 aas and 7 possible TMSs in a 1 + 2 + 2 + 2 TMS arrangement. | None |
Methanobacteriati, Methanobacteriota | TMEM165 family protein of Halomarina litorea |
2.A.106.2.1 | The PFT27 protein of 323 aas with 7 putative TMSs in a 1 + 3 + 3 TMS arrangement, in which the 3 TMS unit is possibly a repeat seqence. | Eukaryota |
Metazoa, Chordata | PFT27 of Mus musculus |
2.A.106.2.2 | Ca2+/Mn2+/Mg2+:H+ antiporter, TMEM165 (PT27; TPARL; SLC64A1) of 324 aas and 7 TMSs in a 1 (N-terminal) + 3 + 3 TMS arrangement (Demaegd et al. 2013). It may be both a Ca2+:H+ and a Mn2+:H+ antiporter (Dulary et al. 2016; Stribny et al. 2020), catalyzing uptake of Mn2+ from the cytoplasm into the golgi lumen. TMEM165 has been linked to congenital disorders of glycosylation (CDG) (Foulquier et al. 2012). It may influence glycosylation due to its Mn2+ transport activity that regulates Mn2+ homeostasis in the golgi (Thines et al. 2018). TMEM165 is also required for milk production (Snyder et al. 2019). In humans, both Ca2+ and Mn2+ are required for proper protein glycosylation in cells (Stribny et al. 2020). TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma, and its depletion impairs invasion activity (Lee et al. 2018). The pathogenicity of TMEM165 variants using structural modeling based on AlphaFold 2 predictions has been presented (Legrand et al. 2023). Mutations in the gene encoding TMEM165 are a cause of a new type of congenital disorder of glycosylation (CDG) (Jankauskas et al. 2024). Comprehensive studies of TMEM165 in different model systems, including mammals, yeast, and fish uncovered the new realm of Mn2+ homeostasis regulation. TMEM165 was shown to act as a Ca2+/Mn2+:H+ antiporter in the medial- and trans-Golgi network, pumping the metal ions into the Golgi lumen and protons outside. Disruption of TMEM165 antiporter activity results in defects in N- and O-glycosylation of proteins and glycosylation of lipids. Impaired glycosylation of TMEM165-CDG arises from a lack of Mn2+ within the Golgi. Nevertheless, Mn2+ insufficiency in the Golgi is compensated by the activity of the ATPase SERCA2. TMEM165 turnover has also been found to be regulated by the Mn2+ cytosolic concentration. Besides causing CDG, the functional involvement of TMEM165 in several other pathologies including cancer and mental health disorders has been described. This systematic review summarizes the available information on TMEM165 molecular structure, cellular function, and its roles in health and disease (Jankauskas et al. 2024). It may catalyze Ca2+ import into lysosomes (Zhang et al. 2025). | Eukaryota |
Metazoa, Chordata | TMEM165 of Homo sapiens (Q9HC07) |
2.A.106.2.3 | Golgi Ca2+:H+ and Mn2+:H+ antiporter, Gdt1 (GCR-1-dependent translation factor 1) or TMEM165 (Demaegd et al., 2013). Involved in ion homeostasis (Dulary et al. 2016), specifically Mn2+ homeostasis (Thines et al. 2018). | Eukaryota |
Fungi, Ascomycota | Gdt1 of Saccharomyces cerevisiae (P38301) |
2.A.106.2.4 | The YD68 protein | Eukaryota |
Fungi, Ascomycota | YD68 of Schizosaccharomyces pombe |
2.A.106.2.5 | Golgi Ca2+ ion homeostasis protein, TM protein PFT27, of 515 aas and 8 putative TMSs in a 2 (N-terminal) + 3 (middle) + 3 (C-terminal) TMSs. | Eukaryota |
Fungi, Ascomycota | Transmembrane protein PFT27 of Pyrenophora tritici-repentis (Wheat tan spot fungus) (Drechslera tritici-repentis) |
2.A.106.3.1 | 3 TMS homologue of 89 aas | Bacteria |
Spirochaetota | 3 TMS homologue of Leptonema illini |
2.A.106.3.2 | 3 TMS homologue of 90 aas | Bacteria |
Bdellovibrionota | 3 TMS homologue of Bdellovibrio bacteriovorus |